We are live on ! Find out more
LUCD icon

Lucid Diagnostics
LUCD

31 hedge funds and large institutions have $5.52M invested in Lucid Diagnostics in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

0.88% less ownership

Funds ownership: 7.35% → 6.48% (-0.88%)

3% less funds holding

Funds holding: 32 → 31 (-1)

39% less capital invested

Capital invested by funds: $9.09M → $5.52M (-$3.57M)

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
5
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LM
Luminus Management
Texas
+$263K
2
Morgan Stanley
Morgan Stanley
New York
+$109K
3
Millennium Management
Millennium Management
New York
+$53.9K
4
E
Ergoteles
New York
+$49.5K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$34.5K

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$813K
2
Northern Trust
Northern Trust
Illinois
-$137K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$111K
4
State Street
State Street
Massachusetts
-$103K
5
BlackRock
BlackRock
New York
-$99.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
– -$137K -40,834 Closed
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
– -$30.6K -13,752 -100%
Charles Schwab
28
Charles Schwab
California
– -$37K -10,913 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– -$12K -3,548 Closed
Deutsche Bank
30
Deutsche Bank
Germany
– -$9K -2,747 Closed
AIG
31
American International Group
New York
– -$8K -2,505 Closed
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
– -$7K -2,008 Closed
Wells Fargo
33
Wells Fargo
California
– -$2.36K -1,063 -97%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
– -$3K -910 Closed
Barclays
35
Barclays
United Kingdom
– -$2K -822 Closed
AB
36
Amalgamated Bank
New York
– -$3K -756 Closed
Citigroup
37
Citigroup
New York
– -$1.44K -650 -93%
Legal & General Group
38
Legal & General Group
United Kingdom
– -$2K -500 Closed
AIP
39
Ameritas Investment Partners
Nebraska
– -$1K -390 Closed
CS
40
Credit Suisse
Switzerland
– +$7 +3 New
HFS
41
Hantz Financial Services
Michigan
– +$22 +10 New
EI
42
Ellevest Inc
New York
– +$60 +27 New
Fidelity Investments
43
Fidelity Investments
Massachusetts
– +$404 +182 New
1
2

LUCD Hedge Fund Activity: Q2 2022 in Review

31 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q2 2022, worth a combined $5.52M — down 39% from $9.09M a quarter earlier.

Fund positioning in LUCD was balanced in Q2 2022: 12 funds opened new positions, 12 closed out, 5 added to existing stakes and 11 trimmed.

The largest buyer was Luminus Management, adding an estimated $263K. The largest seller was Putnam Investments, exiting entirely with an estimated $813K sold.

  • 31 institutional investors held Lucid Diagnostics (LUCD) as of Q2 2022, down from 32 in Q1 2022.
  • Funds reported $5.52M of Lucid Diagnostics stock for Q2 2022, down 39% quarter-over-quarter.
  • 12 funds opened new Lucid Diagnostics positions in Q2 2022 and 12 closed out, a net change of 0 holders.
  • The largest Lucid Diagnostics buyer in Q2 2022 was Luminus Management, an estimated $263K added.
  • The largest Lucid Diagnostics seller in Q2 2022 was Putnam Investments, an estimated $813K sold.

Based on aggregated 13F filings for Q2 2022.